-25% auf alles – bis 31. OktoberKostenloser Versand ab $99 Bestellwert
Biotech Peptides

Verwendung: Dieses Produkt ist ausschließlich für Forschungszwecke bestimmt.

Alle Produktinformationen auf dieser Website dienen ausschließlich Bildungszwecken. Jede Form der Einbringung in den Körper von Menschen oder Tieren ist gesetzlich streng verboten. Dieses Produkt darf nur von zugelassenen und qualifizierten Fachleuten gehandhabt werden. Es ist kein Arzneimittel, Lebensmittel oder Kosmetikum und darf nicht als solches gekennzeichnet, verwendet oder falsch etikettiert werden.

Cartalax, 20mg

Cartalax is a cartilage-derived short peptide bioregulator from the Khavinson series with proposed tissue-specific regulatory activity in cartilaginous tissue.

Menge
Ursprünglicher Preis war: $70.00Aktueller Preis ist: $52.50.
Bewährte Formel. Neues Design.

Während der Umstellung unserer Verpackung erhalten Sie möglicherweise Produkte mit dem bisherigen oder dem neuen Etikett. Formulierung, Reinheit und Qualität bleiben nach unseren Standards genau gleich.

Akzeptierte Zahlungsmethoden
  • Kreditkarte
  • Banküberweisung (SEPA Echtzeit)
  • Banküberweisung (ACH)
  • Wise
  • Revolut
  • Zelle
  • Remitly
  • Western Union
  • Chime
  • Andere

-25% auf alles – bis 31. Oktober
25% auf reguläre Preise statt anderer Angebote. Nur mit dem Krypto-Zahlungsrabatt kombinierbar.

Versand

Versand am selben Tag für US-Bestellungen vor 12 Uhr EST.

Versandbedingungen ansehen →
Rückgabe

30 Tage unkomplizierte Rückgabe ungeöffneter Produkte.

Rückgabebedingungen ansehen →
Laborgeprüft

Jede Charge wird auf Reinheit, Wirksamkeit und Qualität geprüft.

Laborergebnisse ansehen →
Support

Haben Sie eine Frage? Schreiben Sie uns auf Telegram.

Chat öffnen →

Cartalax is a cartilage-derived short peptide bioregulator from the Khavinson series with proposed tissue-specific regulatory activity in cartilaginous tissue. Research from the originating laboratory reports effects on chondrocyte signalling, collagen II synthesis, proteoglycan expression, and extracellular matrix regulation.

Research applications include cartilage biology, chondrocyte function, ECM pathway investigation, and short peptide bioregulator mechanism studies. Independently third-party HPLC-tested; COA available per batch.

  • High Purity – 99% Purity Guaranteed
  • Independently Lab Tested
  • Research Grade Quality
  • For Laboratory Research Use Only

3D Molecular Structure

Drag to rotate · scroll to zoom
Loading 3D structure…
Chemical Formula C12H19N3O8
Synonyms T-31, AED, SCHEMBL5324601, Alanyl-glutamyl-aspartic acid
Molar Mass 333.29 g/mol
CAS Number 205640-90-0
PubChem CID 87815447
Total Compound Content 20 mg per vial
Shelf Life 36 months
Cartalax is a cartilage-derived short peptide bioregulator from the Khavinson series with proposed tissue-specific regulatory activity in cartilaginous tissue. Research from the originating laboratory reports effects on chondrocyte signalling, collagen II synthesis, proteoglycan expression, and extracellular matrix regulation. Research applications include cartilage biology, chondrocyte function, ECM pathway investigation, and short peptide bioregulator mechanism studies. Independently third-party HPLC-tested; COA available per batch.

Every batch is independently lab tested for identity, purity and potency. View our lab testing program →

What cartilage extracellular matrix markers have been examined in Cartalax research?

Research from the originating laboratory has focused on key cartilage extracellular matrix markers including collagen type II, aggrecan, and SOX9, which are central regulators of chondrocyte phenotype and cartilage matrix production. These markers are commonly used to evaluate cartilage signalling, extracellular matrix maintenance, and chondrocyte activity in experimental models.

How does Cartalax fit within the Khavinson bioregulator series?

Cartalax is the cartilage-focused member of the Khavinson peptide bioregulator series. Similar to other organ-specific bioregulators, it is proposed to influence tissue-specific regulatory pathways and is primarily investigated in studies involving cartilage biology, chondrocyte function, extracellular matrix regulation, and peptide-mediated gene expression mechanisms.

What experimental models are commonly used to investigate Cartalax?

Common models include primary chondrocyte cultures, cartilage-derived cell lines, three-dimensional cartilage culture systems, and rodent cartilage research models. Frequently measured endpoints include collagen II expression, aggrecan production, SOX9 signalling, extracellular matrix composition, glycosaminoglycan content, and chondrocyte proliferation markers.

Customer Reviews (9)

★★★★★ ★★★★★
5 / 5
5★
9
4★
0
3★
0
2★
0
1★
0
★★★★★ ★★★★★
Verified Buyer
Anonymous

they finally got back to me we good. I had to email hella tho but they came through. shipment finally moving now

★★★★★ ★★★★★
Verified Buyer
Sasha

Very reliable.Came on time. Amazed by the product.

★★★★★ ★★★★★
Verified Buyer
Anonymous

Great product with delivery. Consistent and safe ordering process.

★★★★★ ★★★★★
Verified Buyer
Phillip

I’m very happy with the product. The quality is excellent, and delivery was prompt.

★★★★★ ★★★★★
Verified Buyer
Boby R.

Perfect service and quality material